Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Opax Investments Inc. is a private asset allocation and investment management firm headquartered in Oakville, Ontario. Established in 1989, the company specializes in the global hedge fund arena and strategic financial consulting for high-net-worth individuals and institutional funds. While not a direct developer of therapeutics, Opax is deeply integrated into the life sciences sector through its management of and association with the Durus Life Sciences Master Fund. The firm's leadership has historically held significant board positions in various biotechnology and medical technology companies, including Aksys and SemBioSys Genetics, facilitating strategic investments and restructuring within the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Opax Investments.